Skip to content

Predictive Value of Heart Rate Variability on Cardiorespiratory Events

Predictive Value of Heart Rate Variability on Cardiorespiratory Events of Preterm Infants Routinely Immunised in the Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04303494
Enrollment
292
Registered
2020-03-11
Start date
2018-07-01
Completion date
2022-11-05
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)

Brief summary

The aim of this study are to investigate whether heart rate variability (HRV) parameters derived from nonlinear time series analysis at five different time points have prognostic utility for assessing the risk of postimmunisation AOP in very preterm/very low birth weight infants immunised in the hospital.

Interventions

BIOLOGICALimmunisation

combined diphtheria, tetanus, acellular pertussis, poliomyelitis, hepatitis B, ± Haemophilus influenzae type B and simultaneous pneumococcus (PCV13) vaccination

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Days to 28 Days

Inclusion criteria

for preterm infants: * Gestational Age (GA) 22+0 to 31+6 weeks and/or birth weight 400 g to 1500 g * Chronological age \> 7 days * Written informed parental consent Inclusion criteria for term healthy control infants: * GA 37 to 42 weeks, chronological age 3 to 28 days (beyond initial transition after birth) * Hospitalised in the neonatal rooming-in unit of the University Children's Hospital Basel as healthy co-twin or healthy sibling, or neonate ready to be discharged home after reconvalescence from minor illness such as hyperbilirubinaemia * Written informed parental consent

Exclusion criteria

* Major congenital malformations including neuromuscular disorders, thoracic malformations, major cardiac malformation * Lack of written informed parental consent

Design outcomes

Primary

MeasureTime frameDescription
Changes in AOPrecord the sum of AOP events from 48 hours windows of raw data, within 24 hours after - 24 hours before immunisationDifference in AOP events within 24 hours after - 24 hours before immunisation

Secondary

MeasureTime frameDescription
Difference in number of manual stimulationsnumber of manual stimulations within 24 hours after - 24 hours before immunisationDifference in number of manual stimulations within 24 hours after - 24 hours before immunisation
Difference in number increases in oxygen concentrationrecord oxygen concentration from 48 hours windows of raw data, within 24 hours after - 24 hours before immunisationDifference in number increases in oxygen concentration within 24 hours after - 24 hours before immunisation
Difference in number of increases in continuous positive airway pressure (CPAP)within 24 hours after - 24 hours before immunisationDifference in number of increases in continuous positive airway pressure (CPAP) within 24 hours after - 24 hours before immunisation
Difference in prolonged hypoxaemic episodesrecord SpO2 from 48 hours windows of raw data, within 24 hours after - 24 hours before immunisationDifference in prolonged hypoxaemic episodes (SpO2 \< 80% for at least 1 min) within 24 hours after - 24 hours before immunisation (CAP-trial definition).
Difference in number of endotracheal intubationwithin 24 hours after - 24 hours before immunisationDifference in number of endotracheal intubation for AOP events within 24 hours after - 24 hours before immunisation
Difference in sample entropy (SampEn) of interbeat interval of heart rate (IBI)24 hours after - immediately prior to immunisationDifference in SampEn of IBI 24 hours after - immediately prior to immunisation
Difference in SampEn of IBIpreterm infants measured at 37 to 42 weeksDifference in SampEn of IBI in preterm infants measured at 37 to 42 weeks postconceptional age vs. SampEn of IBI in term healthy control infants
Difference in number of reinstallations in continuous positive airway pressure (CPAP)within 24 hours after - 24 hours before immunisationDifference in number of reinstallations in continuous positive airway pressure (CPAP) within 24 hours after - 24 hours before immunisation

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026